Press "Enter" to skip to content

New patent expiration for Biogen Idec drug SPINRAZA


Annual Drug Patent Expirations for SPINRAZA
Annual Drug Patent Expirations for SPINRAZA

Spinraza is a drug marketed by Biogen Idec
and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has five hundred and forty-one patent family members in twenty-five countries.

The generic ingredient in SPINRAZA is nusinersen sodium. One supplier is listed for this compound. Additional details are available on the nusinersen sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!